Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to...
3 insider purchases on record · latest filing 2020-10-29.
Insiders have also filed 8 sale transactions at FHTX.